Shan Li

761 total citations
57 papers, 494 citations indexed

About

Shan Li is a scholar working on Epidemiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shan Li has authored 57 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 11 papers in Molecular Biology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shan Li's work include Liver Disease Diagnosis and Treatment (18 papers), Lipid metabolism and disorders (6 papers) and Sepsis Diagnosis and Treatment (6 papers). Shan Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Lipid metabolism and disorders (6 papers) and Sepsis Diagnosis and Treatment (6 papers). Shan Li collaborates with scholars based in China, United States and Canada. Shan Li's co-authors include Ying Xu, Jianchun Pan, Linlin Zhen, Xin Zhao, Xia Du, Yiran An, Qiandong Wang, Wenting You, Xiaonan Dong and Bao‐Shan Ku and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Shan Li

50 papers receiving 491 citations

Peers

Shan Li
Ali A. Abo‐Saif Egypt
Yongli Zhan China
Walaa Yehia Abdelzaher Egypt
Bin Gao China
Ahmed Al-Shukaili Oman
Mariateresa Ambrosio Italy
Jia Song China
Ayesha Rahman United States
Mohammed S. El‐Awady Egypt
Lianhong Zou China
Ali A. Abo‐Saif Egypt
Shan Li
Citations per year, relative to Shan Li Shan Li (= 1×) peers Ali A. Abo‐Saif

Countries citing papers authored by Shan Li

Since Specialization
Citations

This map shows the geographic impact of Shan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Li more than expected).

Fields of papers citing papers by Shan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Li. The network helps show where Shan Li may publish in the future.

Co-authorship network of co-authors of Shan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Li. A scholar is included among the top collaborators of Shan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Li. Shan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Cong, et al.. (2025). Pachymic Acid Ameliorates Fructose-Driven Hyperuricemic Nephropathy in Mice by Suppressing Ferroptosis via Activating Nrf2/GPX-4 Pathway. Journal of Agricultural and Food Chemistry. 73(36). 22778–22793.
2.
Deng, Shengqiong, et al.. (2025). Lymphatic Endothelial C‐C Motif Chemokine Ligand 2 Enhances Lymphangiogenesis and Lymphatic Clearance of Macrophages Following Myocardial Infarction. Journal of the American Heart Association. 15(1). e039153–e039153.
3.
Zhang, Xinyun, Hong‐Ru Lin, Mengchen Wu, et al.. (2025). Negative Effect of Gst‐35 on the Health Span of Caenorhabditis elegans Through Lysosomal Dysfunction via the Pmk‐1 and Skr Genes. Aging Cell. 24(6). e70016–e70016.
4.
5.
6.
7.
Sun, Qin-Juan, Shan Li, Ritian Lin, et al.. (2024). hUC-MSCs therapy for Crohn’s disease: efficacy in TNBS-induced colitis in rats and pilot clinical study. EBioMedicine. 103. 105128–105128. 12 indexed citations
8.
Cai, Xueli, Yanli Zhang, Suying Wang, et al.. (2024). Metabolic dysfunction–associated fatty liver disease is associated with the presence of coronary atherosclerotic plaques and plaque burden. Hellenic Journal of Cardiology. 86. 91–99. 1 indexed citations
9.
10.
Luo, Haihua, et al.. (2023). Integrated Analyses of Single-Cell Transcriptome and Mendelian Randomization Reveal the Protective Role of Resistin in Sepsis Survival in Intensive Care Unit. International Journal of Molecular Sciences. 24(19). 14982–14982. 3 indexed citations
11.
Dong, Run, Jinmin Peng, Yan Chen, et al.. (2023). Validation of an ICD-Based Algorithm to Identify Sepsis: A Retrospective Study. Risk Management and Healthcare Policy. Volume 16. 2249–2257. 2 indexed citations
12.
Shi, Hui, Chunyan Xing, Shan Li, et al.. (2022). An injectable thermosensitive hydrogel for dual delivery of diclofenac and Avastin® to effectively suppress inflammatory corneal neovascularization. International Journal of Pharmaceutics. 625. 122081–122081. 20 indexed citations
13.
Jiang, Qiuyue, Zhilong Lin, Zhuowei Su, et al.. (2022). Peptide identification of hepatocyte growth-promoting factor and its function in cytoprotection and promotion of liver cell proliferation through the JAK2/STAT3/c-MYC pathway. European Journal of Pharmacology. 920. 174832–174832. 5 indexed citations
14.
Li, Shan, Jia Zhou, Jie Yu, et al.. (2019). Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus. Inflammopharmacology. 27(3). 511–520. 8 indexed citations
15.
Zhou, Jia, Shan Li, Zhijun Xie, et al.. (2019). Analysis of brain metabolites by gas chromatography–mass spectrometry reveals the risk–benefit concerns of prednisone in MRL/lpr lupus mice. Inflammopharmacology. 28(2). 425–435. 2 indexed citations
16.
Sanghez, Valentina, Shan Li, Tsui‐Fen Chou, et al.. (2018). Efficacy of Asparaginase Erwinia chrysanthemi With and Without Temozolomide Against Glioma Cells and Intracranial Mouse Medulloblastoma. Anticancer Research. 38(5). 2627–2634. 6 indexed citations
17.
Chen, Xiuhua, et al.. (2014). Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow. Coronary Artery Disease. 26(2). 114–120. 28 indexed citations
18.
Deng, Yan, Meng Li, Jian Wang, et al.. (2014). Susceptibility to hepatocellular carcinoma in the Chinese population—associations with interleukin-6 receptor polymorphism. Tumor Biology. 35(7). 6383–6388. 9 indexed citations
19.
Zhen, Linlin, Xin Zhao, Yiran An, et al.. (2011). The antidepressant-like effect of fisetin involves the serotonergic and noradrenergic system. Behavioural Brain Research. 228(2). 359–366. 77 indexed citations
20.
Zeng, Xiaoning, et al.. (2010). Analysis of patents on anti-allergic therapies issued in China from 1988 to 2008. Expert Opinion on Therapeutic Patents. 20(6). 727–737. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali A. Abo‐Saif Breakdown of academic impact, for papers by Yongli Zhan Breakdown of academic impact, for papers by Walaa Yehia Abdelzaher Breakdown of academic impact, for papers by Bin Gao Breakdown of academic impact, for papers by Ahmed Al-Shukaili Breakdown of academic impact, for papers by Mariateresa Ambrosio Breakdown of academic impact, for papers by Jia Song Breakdown of academic impact, for papers by Ayesha Rahman Breakdown of academic impact, for papers by Mohammed S. El‐Awady Breakdown of academic impact, for papers by Lianhong Zou
Rankless by CCL
2026